M

Monograph Capital

14 employees

Monograph Capital is a life sciences venture firm.

Investor insights

Sectors invested in

Biotechnology4
Information Technology2
Life Science2
Therapeutics2
SaaS1
regulatory consulting1
regulatory intelligence1
Professional Services1
importation1
cosmetics regulatory compliance1
RegTech1
regulatory strategy1
food and drug compliance1
regulatory affairs consulting1
decentralized clinical trials compliance1
product labeling1
regulatory research1
path to market1
FMCG1
SaaS platform1

Funding rounds participated in

$10 sweet spot round size

Most of their 6 investments are in rounds between $16M and $97M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Date founded

2021

Investments made

O

ODAIA raised $25M on May 1, 2023

Investors: Flint Capital, Panache Ventures, Innospark Ventures, StandUp Ventures, MaRS Investment Accelerator Fund, Threshold Ventures, Wittington Ventures, Graphite Ventures and Monograph Capital

M

Maxion Therapeutics raised $16M on February 15, 2023

Investors: Monograph Capital

R

RegASK™ raised $10M on December 16, 2022

Investors: Monograph Capital

H

HIBio raised $120M on November 1, 2022

Investors: ARCH Venture Partners, JEITO and Monograph Capital

M

MiroBio Ltd raised $97M on June 29, 2022

Investors: Oxford Sciences Innovation, OrbiMed Advisors, Advent Life Sciences, Samsara BioCapital, S.R. One Ltd, Medicxi and Monograph Capital

A

AviadoBio raised $78M on December 2, 2021

Investors: EQT Life Sciences, F-Prime Capital Partners, The Dementia Discovery Fund, Advent Life Sciences and Monograph Capital

FAQ